Interesting CAVA Put And Call Options For March 27th

The piece outlines option strategies for CAVA Group (stock price $63.63): a sell-to-open $62 put (bid $3.00) would set an effective purchase basis of $59.00, is ~3% out-of-the-money, carries a 60% chance to expire worthless and would yield 4.84% (35.35% annualized) if it does. A covered-call using the $67 strike (bid $3.75) on shares purchased at $63.63 would produce an 11.19% total return if assigned by the March 27 expiration, is ~5% out-of-the-money with a 52% chance to expire worthless and would boost return 5.89% (43.06% annualized). Implied volatilities are 64% (put) and 70% (call), versus a 12‑month trailing volatility of 58%, and Stock Options Channel will track odds and contract histories on its site.

Analysis

Market structure: Elevated IV (64–70% vs realized 58%) makes option sellers and market‑making desks near‑term winners — they collect outsized premia while retail buyers pay for protection. CAVA shareholders face a tradeoff: sell premium (puts/calls) to harvest 4.8–5.9% yields to March 27, or risk being assigned/Called away; liquidity and delta‑hedging flows will accentuate intraday moves around news. Cross‑asset impact is limited to equity‑vol channeling: significant option selling or buying can move CAVA shares and local equity vol without meaningful bond/FX spillover.

Risk assessment: Immediate (days–weeks) risk centers on IV crush or earnings/traffic miss that can swing ±20–40% intraday and flip put odds; short term (to March 27) tail is assignment or large gap down from commodity/cost shocks. Long term (quarters) depends on SSS recovery and unit economics — a positive re‑rating can leave covered sellers exposed to 20–50% upside forgone. Hidden dependencies: pin risk near $62/$67, early exercise around ex‑dividends/promotions, and broker margin/assignment mechanics that can force capital redeployment.

Trade implications: Prefer defined‑risk credit strategies over naked exposure. Sell March27 CAVA $62/$58 put credit spreads (width 4 points) to target net credit ≥$2.50 (~≥6% of width) only if IV stays >60% and allocate 1–2% portfolio notional; if assigned, effective cost basis ≤$59. For existing longs, sell March27 $67 covered calls to harvest ~11.2% to expiry but buy back >$69 or on IV drop <50%.

Contrarian angles: Consensus treats YieldBoost as “free” income; it understates opportunity cost of missed re‑rating — if CAVA posts strong comps, covered sellers materially underperform. The market may be underpricing upside persistence in restaurant rollups; conversely, premium compression post‑earnings can make short premium strategies less attractive. Unintended consequence: repeated use of these tactics can crowd the strikes and worsen liquidity/realized slippage at assignment moments.

Key Decisions for Investors

• Establish sell-to-open March27 CAVA $62/$58 put credit spreads (1–3 contracts per $1M AUM, ~1–2% portfolio notional). Target net credit ≥$2.50 (~$250 per spread); max loss = $400 - credit. Only execute if IV ≥60% and market odds OTM ≥60%; stop-loss/close if CAVA < $56 or IV spikes >+15pt.
• If willing to own shares, sell-to-open a naked March27 CAVA $62 put sized to 0.5–1.0% of portfolio with 100% cash reserve for assignment (effective basis target ≤$59). Close or roll if price falls below $60 or realized vol 30‑day >80%.
• For existing CAVA longs, sell March27 $67 covered calls to collect ~$3.75 (11.2% to expiry). Buy back calls if stock > $69, IV drops below 50%, or fundamental catalysts (earnings, same‑store sales) are announced before expiry.
• Relative value: over‑weight CAVA vs under‑weight XLY (consumer discretionary ETF) by 0.5–1% net for 3–6 months to express stock‑specific execution/upside while hedging sector cyclicality; trim if XLY outperforms by >5% in 30 days.